204 related articles for article (PubMed ID: 35193610)
1. Immune cell profiles of patients with interstitial cystitis/bladder pain syndrome.
Moldwin RM; Nursey V; Yaskiv O; Dalvi S; Macdonald EJ; Funaro M; Zhang C; DeGouveia W; Ruzimovsky M; Rilo HR; Miller EJ; Najjar S; Tabansky I; Stern JNH
J Transl Med; 2022 Feb; 20(1):97. PubMed ID: 35193610
[TBL] [Abstract][Full Text] [Related]
2. The bacterial microbiota of Hunner lesion interstitial cystitis/bladder pain syndrome.
Nickel JC; Ehrlich GD; Krol JE; Ahmed A; Sen B; Bhat A; Mell JC; Doiron RC; Kelly KL; Earl JP
BJU Int; 2022 Jan; 129(1):104-112. PubMed ID: 34143561
[TBL] [Abstract][Full Text] [Related]
3. Small Fiber Polyneuropathy in Hunner Lesion and Non-Hunner Lesion Interstitial Cystitis/Bladder Pain Syndrome.
Han E; Killinger KA; Turner KM; Gilleran J; Tenney D; Peters KM
Female Pelvic Med Reconstr Surg; 2021 Jan; 27(1):e91-e95. PubMed ID: 32217920
[TBL] [Abstract][Full Text] [Related]
4. Clinical characterization of interstitial cystitis/bladder pain syndrome in women based on the presence or absence of Hunner lesions and glomerulations.
Watanabe D; Akiyama Y; Niimi A; Nomiya A; Yamada Y; Sato Y; Nakamura M; Kawai T; Yamada D; Suzuki M; Igawa Y; Kume H; Homma Y
Low Urin Tract Symptoms; 2021 Jan; 13(1):139-143. PubMed ID: 32830459
[TBL] [Abstract][Full Text] [Related]
5. Elevated Urine Levels of Macrophage Migration Inhibitory Factor in Inflammatory Bladder Conditions: A Potential Biomarker for a Subgroup of Interstitial Cystitis/Bladder Pain Syndrome Patients.
Vera PL; Preston DM; Moldwin RM; Erickson DR; Mowlazadeh B; Ma F; Kouzoukas DE; Meyer-Siegler KL; Fall M
Urology; 2018 Jun; 116():55-62. PubMed ID: 29580781
[TBL] [Abstract][Full Text] [Related]
6. Pathology and terminology of interstitial cystitis/bladder pain syndrome: A review.
Akiyama Y; Homma Y; Maeda D
Histol Histopathol; 2019 Jan; 34(1):25-32. PubMed ID: 30015351
[TBL] [Abstract][Full Text] [Related]
7. Urine cytokines as biomarkers for diagnosing interstitial cystitis/bladder pain syndrome and mapping its clinical characteristics.
Jiang YH; Jhang JF; Hsu YH; Ho HC; Wu YH; Kuo HC
Am J Physiol Renal Physiol; 2020 Jun; 318(6):F1391-F1399. PubMed ID: 32281420
[TBL] [Abstract][Full Text] [Related]
8. Urinary IL-33 and galectin-3 increase in patients with interstitial cystitis/bladder pain syndrome (review).
Kochiashvili G; Kochiashvili D
Georgian Med News; 2014; (232-233):12-5. PubMed ID: 25214264
[TBL] [Abstract][Full Text] [Related]
9. Local immune response in bladder pain syndrome/interstitial cystitis ESSIC type 3C.
Gamper M; Viereck V; Eberhard J; Binder J; Moll C; Welter J; Moser R
Int Urogynecol J; 2013 Dec; 24(12):2049-57. PubMed ID: 23670165
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers in Interstitial Cystitis/Bladder Pain Syndrome with and without Hunner Lesion: A Review and Future Perspectives.
Akiyama Y
Diagnostics (Basel); 2021 Nov; 11(12):. PubMed ID: 34943475
[TBL] [Abstract][Full Text] [Related]
11. Potential Urine and Serum Biomarkers in Patients with Bladder Pain Syndrome/Interstitial Cystitis.
Wang L; Gao J; Zheng S; Wang Z; Zheng S; Luo Z
Arch Esp Urol; 2024 May; 77(4):353-358. PubMed ID: 38840277
[TBL] [Abstract][Full Text] [Related]
12. Current best practice management of interstitial cystitis/bladder pain syndrome.
Han E; Nguyen L; Sirls L; Peters K
Ther Adv Urol; 2018 Jul; 10(7):197-211. PubMed ID: 30034539
[TBL] [Abstract][Full Text] [Related]
13. Bioenergetic profiles of peripheral mononuclear cells and systemic inflammation in women with Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS).
Kumar P; Oster RA; Assimos DG; Ness TJ; Mitchell T
PLoS One; 2024; 19(2):e0298981. PubMed ID: 38359038
[TBL] [Abstract][Full Text] [Related]
14. Urine nerve growth factor (NGF) level, bladder nerve staining and symptom/problem scores in patients with interstitial cystitis.
Tonyali S; Ates D; Akbiyik F; Kankaya D; Baydar D; Ergen A
Adv Clin Exp Med; 2018 Feb; 27(2):159-163. PubMed ID: 29521057
[TBL] [Abstract][Full Text] [Related]
15. Is There a Role for Bladder Biopsy in the Diagnosis of Non-Hunner Lesions Interstitial Cystitis?
Natale F; Campagna G; Marturano M; Caramazza D; Panico G; Vacca L; Torcia E; Cervigni M; Scambia G; Ercoli A
Urol Int; 2023; 107(3):257-262. PubMed ID: 35896088
[TBL] [Abstract][Full Text] [Related]
16. Current Understanding and Future Perspectives of Interstitial Cystitis/Bladder Pain Syndrome.
Ueda T; Hanno PM; Saito R; Meijlink JM; Yoshimura N
Int Neurourol J; 2021 Jun; 25(2):99-110. PubMed ID: 34218637
[TBL] [Abstract][Full Text] [Related]
17. Increased pro-inflammatory cytokines, C-reactive protein and nerve growth factor expressions in serum of patients with interstitial cystitis/bladder pain syndrome.
Jiang YH; Peng CH; Liu HT; Kuo HC
PLoS One; 2013; 8(10):e76779. PubMed ID: 24146927
[TBL] [Abstract][Full Text] [Related]
18. Urinary nerve growth factor level is increased in patients with interstitial cystitis/bladder pain syndrome and decreased in responders to treatment.
Liu HT; Tyagi P; Chancellor MB; Kuo HC
BJU Int; 2009 Nov; 104(10):1476-81. PubMed ID: 19522864
[TBL] [Abstract][Full Text] [Related]
19. Temporally complex inflammatory networks in an animal model reveal signatures for interstitial cystitis and bladder pain syndrome phenotype.
Shah AM; Vodovotz Y; Yoshimura N; Chermansky CJ; Fitzgerald J; Tyagi P
Neurourol Urodyn; 2023 Nov; 42(8):1839-1848. PubMed ID: 37587846
[TBL] [Abstract][Full Text] [Related]
20. Urinary Biomarkers in Interstitial Cystitis/Bladder Pain Syndrome and Its Impact on Therapeutic Outcome.
Lin HY; Lu JH; Chuang SM; Chueh KS; Juan TJ; Liu YC; Juan YS
Diagnostics (Basel); 2021 Dec; 12(1):. PubMed ID: 35054241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
